I
T is a common opinion among neurosurgeons and neurologists that damage to the rostral brain stem is associated with, and probably responsible for, coma. The reticular formation is considered to be the brain stem structure whose integrity is essential for a normal level of consciousness. There are many publications dealing with this subject and supporting this view. 46 On the other hand, some recent observations in our laboratory on the effect of barbiturate injection into the vertebral circulation of man, 2,~,6 seem to lead to different conclusions. No distinct change in the level of consciousness was recorded following the direct introduction of amobarbital sodium (Amytal) into one vertebral artery. The brain stem up to the caudal thalamus usually receives its blood supply from the vertebral arteries. 26 A drug injected directly into these vessels, therefore, is likely to affect the neurons of the brain stem structures selectively. In the case of intravertebral injection of a barbiturate depression of brain stem activity should occur. This has actually been demonstrated in experiments on cats 31 and rabbits. 21,43 The sensitivity of the reticular formation to barbiturates is well known. 8,13, ls,19.25 Therefore, if the maintenance of a normal level of consciousness is dependent upon reticular function, the intravertebral administration of a barbiturate should always result in loss of consciousness.
The apparent discrepancy between generally accepted views on the neural mechanism of consciousness and our findings led us to re-investigate our previous finding 2,s of absence of any effect from intravertebral amobarbital on the level of consciousness. We then tried to find out whether brain stem structures such as the nuclei of cranial nerves having a well-known function were affected; in particular, we wanted to make sure that the brain stem neurons are really depressed by intravertebral amobarbital. Thirdly, we tried to discover whether the barbiturate is distributed to all levels of the brain stem, including the rostral midbrain; this was done by examining the somatomotor, visceromotor and somato sensory functions of certain cranial nerves. Fourthly, the possibility of difference in sensitivity to barbiturates in the various brain stem structures or functions was considered. Finally, an analysis was made of the effects of barbiturates on electroencephalographic activity.
The results reported below were found in patients who had to undergo intravertebral amobarbital injection for diagnostic purposes. Direct introduction of this barbiturate into the cerebral circulation is usually limited to the carotid system; this technique is used by us and by others for the identification of cerebral dominance, 1, 3, 9, 16, [39] [40] [41] 44, [55] [56] [57] [58] [59] [60] [61] [62] [63] for the identification of the focus in epileptic patients, 17,3s,51'52 and for the study of diskinetic and distonic disease, a,6,22,3~ The first injections of amobarbital into the vertebral system of man were made accidentally while attempting an intracarotid injection. 2 Intravertebral amobarbital was found not to be dangerous in these first fortuitous cases. We therefore decided to apply this method to the study of epilepsy and certain extrapyramidal diseases. All the studies were performed with the full knowledge of the patient who had previously been informed of their nature. In all patients the intravertebral amobarbital injection was immediately preceded by vertebral angiography. We have reported 629 here only those cases showing a normal angiographic picture.
Method
Nineteen patients with a normal angiographic picture of the vertebro-basilar arterial system were examined. The vertebral artery, usually on the right side, was reached percutaneously in the neck according to the technique of Lindgren. The amount of amobarbital used ranged between 3 and 100 mg. The drug was diluted to 1-5 per cent with saline or distilled water and injected over about 3 seconds. The electroencephalogram (EEG), electrocardiogram, frequency of respiration and electrical activity of some muscular groups were continuously recorded on an inkwriting electroencephalograph. The blood pressure was measured with a Riva Rocci instrument. The motor component of the 3rd, 4th, 5th, 6th, 7th and l~th cranial nerves was examined by direct observation of their function. Particular attention was devoted to the pupillary size. The sensory function of the 5th nerve was examined through tactile and pain stimulation. Simple motor and sensory examination of at least one arm or leg was usually performed. As already described, 2 evaluation of the level of consciousness was based on the following criteria: general behavior of the patient; his ability to react correctly to the order to perform a given movement, an order which was given before or immediately after the injection of the barbiturate, and his capacity to recollect afterwards what was said or done during the examination. The intravertebral injection of amobarbital was always preceded by the injection of an equal amount of saline: the latter never produced any neurological or EEG effect.
Results
Motor functions. The first motor phenomenon which followed the intravertebral injection of a very low dose of amobarbital (10-~0 mg.) was nystagmus; ~ or 3 seconds after the beginning of the injection, there was horizontal nystagmus; the direction of the rapid and slow components was not constantly related to the side of the injection. The nystagmus disappeared within 40-60 seconds, but in some instances it could be observed even after 4-5 minutes during lateral gaze.
Dose of 30-60 mg. of the drug always produced the following immediate paretic phenomena in the muscles innervated by the cranial nerves : bilateral ptosis of the superior eyelids, variable deviation of the eyes, opening of the mouth because of loss of tone in the jaw muscles (the jaw did not deviate to right or left), bilateral smoothing of the nasolabial furrow, puffing out of both cheeks with respiration, and inability to protrude the tongue. These paretic phenomena lasted about 3-4 minutes.
Postural fixation and movements of the limbs were preserved; after the injection the subject was still capable of maintaining his arms horizontally extended in front of him, or to perform voluntary movements. There were, however, errors in rate, range and direction of movements of the arms that revealed a disturbance of coordination.
Sensory functions. The most obvious and constant sensory disturbance was vertigo. Even with low doses (10-~0 mg.) of amobarbital the patient complained that the external world appeared to move, usually in a rotary fashion. With larger doses of the drug the phenomenon was much more marked and disturbing.
Sensitivity to light touch and pin prick in the cutaneous sensory field of the 5th nerve was sometimes reduced by 30-60 mg. of barbiturate. The hypesthesia appeared almost immediately after the intravertebral injection and gradually disappeared in about minutes. Unlike the motor deficit, the sensory defects were not observed in all patients.
We never observed loss of hearing nor impairment in the appreciation of vibratory, tactile and painful stimuli applied to the four limbs. However, the examination of the auditory function was not carried out with a technique sufficiently refined to reveal the possible existence of slight deafness.
Visceral functions. A marked dilatation of both pupils was always produced by the doses of amobarbital causing oculomotor and facial paralysis (30-60 mg.). The mydriasis immediately following the injection of the drug disappeared gradually in 3--4 minutes. The blood pressure was not depressed even by 100 mg. of amobarbital. Only slight and short lasting irregularity in the respiratory rhythm was observed. The heart frequency was usually increased during the ~0-30 seconds which followed the injection.
Reflexes. The pupillary light reflex and the corneal reflex were suppressed bilaterally by 30-60 mg. of amobarbital. They disappeared simultaneously with the appearance of ocu-
